JPMorgan analyst James Gordon raised the firm’s price target on AstraZeneca to 14,000 GBp from 13,500 GBp and keeps an Overweight rating on the shares.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AZN:
JPMorgan analyst James Gordon raised the firm’s price target on AstraZeneca to 14,000 GBp from 13,500 GBp and keeps an Overweight rating on the shares.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AZN: